Evidence-based clinical practice guidelines for polycystic kidney disease 2014

Shigeo Horie; Toshio Mochizuki; Satoru Muto; Kazushige Hanaoka; Yoshimitsu Fukushima; Ichiei Narita; Kikuo Nutahara; Ken Tsuchiya; Kazuhiko Tsuruya; Koichi Kamura; Saori Nishio; Tatsuya Suwabe; Yoshifumi Ubara; Eiji Ishimura; Koichi Nakanishi; Keiichi Furukawa; Kenjiro Kimura; Seiichi Matsuo

doi:10.1007/s10157-015-1219-7

Evidence-based clinical practice guidelines for polycystic kidney disease 2014

Shigeo Horie, Toshio Mochizuki, Satoru Muto, Kazushige Hanaoka, Yoshimitsu Fukushima, Ichiei Narita, Kikuo Nutahara, Ken Tsuchiya, Kazuhiko Tsuruya, Koichi Kamura, Saori Nishio, Tatsuya Suwabe, Yoshifumi Ubara, Eiji Ishimura, Koichi Nakanishi, Keiichi Furukawa, Kenjiro Kimura, Seiichi Matsuo

医学研究院

研究成果: ジャーナルへの寄稿 › 総説 › 査読

24 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	493-509
ページ数	17
ジャーナル	Clinical and Experimental Nephrology
巻	20
号	4
DOI	https://doi.org/10.1007/s10157-015-1219-7
出版ステータス	出版済み - 8月 1 2016

!!!All Science Journal Classification (ASJC) codes

生理学
腎臓病学
生理学（医学）

文献へのアクセス

10.1007/s10157-015-1219-7

他のファイルとリンク

引用スタイル

Horie, S., Mochizuki, T., Muto, S., Hanaoka, K., Fukushima, Y., Narita, I., Nutahara, K., Tsuchiya, K., Tsuruya, K., Kamura, K., Nishio, S., Suwabe, T., Ubara, Y., Ishimura, E., Nakanishi, K., Furukawa, K., Kimura, K., & Matsuo, S. (2016). Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clinical and Experimental Nephrology, 20(4), 493-509. https://doi.org/10.1007/s10157-015-1219-7

Horie, S, Mochizuki, T, Muto, S, Hanaoka, K, Fukushima, Y, Narita, I, Nutahara, K, Tsuchiya, K, Tsuruya, K, Kamura, K, Nishio, S, Suwabe, T, Ubara, Y, Ishimura, E, Nakanishi, K, Furukawa, K, Kimura, K & Matsuo, S 2016, 'Evidence-based clinical practice guidelines for polycystic kidney disease 2014', Clinical and Experimental Nephrology, vol. 20, no. 4, pp. 493-509. https://doi.org/10.1007/s10157-015-1219-7

@article{b708b72fa63e48a4a099e4b587c45e68,

title = "Evidence-based clinical practice guidelines for polycystic kidney disease 2014",

author = "Shigeo Horie and Toshio Mochizuki and Satoru Muto and Kazushige Hanaoka and Yoshimitsu Fukushima and Ichiei Narita and Kikuo Nutahara and Ken Tsuchiya and Kazuhiko Tsuruya and Koichi Kamura and Saori Nishio and Tatsuya Suwabe and Yoshifumi Ubara and Eiji Ishimura and Koichi Nakanishi and Keiichi Furukawa and Kenjiro Kimura and Seiichi Matsuo",

note = "Funding Information: Guidelines on four diseases (IgA nephropathy, nephrotic syndrome, RPGN, and polycystic kidney disease [PKD]) were created simultaneously by a research group on progressive kidney disorders (led by Seiichi Matsuo) funded by the Ministry of Health, Labour, and Welfare{\textquoteright}s research project for overcoming intractable diseases. All of these guidelines have the same chapter structure. PKD is a genetic disease, so Shinshu University professor Yoshimitsu Fukushima assisted by serving on the drafting committee as a representative of the Japan Society of Human Genetics. Keiichi Furukawa of the Division of Infectious Diseases in the Department of Internal Medicine at St. Luke{\textquoteright}s International Hospital provided assistance regarding cyst infections. We would like to take this opportunity to thank these two physicians for their generous help. ",

year = "2016",

month = aug,

day = "1",

doi = "10.1007/s10157-015-1219-7",

language = "English",

volume = "20",

pages = "493--509",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer Japan",

number = "4",

}

TY - JOUR

T1 - Evidence-based clinical practice guidelines for polycystic kidney disease 2014

AU - Horie, Shigeo

AU - Mochizuki, Toshio

AU - Muto, Satoru

AU - Hanaoka, Kazushige

AU - Fukushima, Yoshimitsu

AU - Narita, Ichiei

AU - Nutahara, Kikuo

AU - Tsuchiya, Ken

AU - Tsuruya, Kazuhiko

AU - Kamura, Koichi

AU - Nishio, Saori

AU - Suwabe, Tatsuya

AU - Ubara, Yoshifumi

AU - Ishimura, Eiji

AU - Nakanishi, Koichi

AU - Furukawa, Keiichi

AU - Kimura, Kenjiro

AU - Matsuo, Seiichi

N1 - Funding Information: Guidelines on four diseases (IgA nephropathy, nephrotic syndrome, RPGN, and polycystic kidney disease [PKD]) were created simultaneously by a research group on progressive kidney disorders (led by Seiichi Matsuo) funded by the Ministry of Health, Labour, and Welfare’s research project for overcoming intractable diseases. All of these guidelines have the same chapter structure. PKD is a genetic disease, so Shinshu University professor Yoshimitsu Fukushima assisted by serving on the drafting committee as a representative of the Japan Society of Human Genetics. Keiichi Furukawa of the Division of Infectious Diseases in the Department of Internal Medicine at St. Luke’s International Hospital provided assistance regarding cyst infections. We would like to take this opportunity to thank these two physicians for their generous help.

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=84964385389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964385389&partnerID=8YFLogxK

U2 - 10.1007/s10157-015-1219-7

DO - 10.1007/s10157-015-1219-7

M3 - Review article

AN - SCOPUS:84964385389

VL - 20

SP - 493

EP - 509

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 4

ER -